Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...

New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs ...

With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations ...

"This is a real concern for all patients who have been benefiting from this medicine. There will be panic and hysteria out ...

Thousands of overweight people are to be prescribed low-calorie soups and shakes on the NHS in a radical bid to tackle ...

Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, ...

It’s no secret that obesity is becoming an epidemic in the United  States. It’s estimated that by 2030, 50 percent of ...

Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...

As the cost of Mounjaro jabs is set to increase by as much as 170 per cent, Jade Kay, who has already spent £2.4k on the drug ...

Emilly Murray, 35, weighed 22st 1.5lbs and was struggling to squeeze into a size 30 at her heaviest - but has now lost 11 ...

Two new studies that have been published recently show that people who have been taking weight loss drugs may have ...